From its inception, Mary Crowley Cancer Research has focused on personalized (patient-specific), personalized (cancer-specific) therapeutics as the gateway to cancer control and, ultimately, to a higher probability of cure.
In this effort, Mary Crowley has functioned not only as a conduit of state-of-the-art treatment modalities but also as an innovator and contributor to conceptual development and translational applications.
Featured ResourcesSee All
Featured PublicationsSee All
Featured White PapersSee All
CLINICAL UPDATE OF BI-SHRNA FURIN/GMCSF DNA TRANSFECTED TUMOR VACCINE: FANG IN CANCER PATIENTS
CLINICAL UPDATE OF BIFUNCTIONAL (BI)-SHRNAI NANOPLEX TECHNOLOGY IN CANCER
MOLECULAR MAPPING FOR PERSONALIZED CANCER THERAPEUTICS
Connect With Us
Whether you want to give a spark of hope or you are looking for it, we are here to help. If you have any questions or concerns, please contact us here.